Mapping the road to elimination: a 5-year evaluation of implementation strategies associated with hepatitis C treatment in the veterans health administration

• Published in: BMC health services research 2021-12, Vol.21 (1), p.1348-1348, Article 1348
• Main Authors: Yakovchenko, Vera, Morgan, Timothy R, Chinman, Matthew J, Powell, Byron J, Gonzalez, Rachel, Park, Angela, Malone, Patrick S, Chartier, Maggie, Ross, David, Rogal, Shari S
• Format: Article
• Language: English
• Subjects: Cirrhosis; Collaboration; Diffusion of innovation; Endorsements; Health care policy; Health services; Hepatitis; Hepatitis C; Hepatitis C - drug therapy; Hepatitis C - epidemiology; Hepatitis C - prevention & control; Humans; Implementation; Innovations; Liver; Liver cirrhosis; Longitudinal Studies; Patients; Quality improvement; Veterans; Veterans Health
• ISSN: 1472-6963; 1472-6963
• DOI: 10.1186/s12913-021-07312-4

While few countries and healthcare systems are on track to meet the World Health Organization's hepatitis C virus (HCV) elimination goals, the US Veterans Health Administration (VHA) has been a leader in these efforts. We aimed to determine which implementation strategies were associated with successful national viral elimination implementation within the VHA. We conducted a five-year, longitudinal cohort study of the VHA Hepatic Innovation Team (HIT) Collaborative between October 2015 and September 2019. Participants from 130 VHA medical centers treating HCV were sent annual electronic surveys about their use of 73 implementation strategies, organized into nine clusters as described by the Expert Recommendations for Implementing Change taxonomy. Descriptive and nonparametric analyses assessed strategy use over time, strategy attribution to the HIT, and strategy associations with site HCV treatment volume and rate of adoption, following the Theory of Diffusion of Innovations. Between 58 and 109 medical centers provided responses in each year, including 127 (98%) responding at least once, and 54 (42%) responding in all four implementation years. A median of 13-27 strategies were endorsed per year, and 8-36 individual strategies were significantly associated with treatment volume per year. Data warehousing, tailoring, and patient-facing strategies were most commonly endorsed. One strategy-"identify early adopters to learn from their experiences"-was significantly associated with HCV treatment volume in each year. Peak implementation year was associated with revising professional roles, providing local technical assistance, using data warehousing (i.e., dashboard population management), and identifying and preparing champions. Many of the strategies were driven by a national learning collaborative, which was instrumental in successful HCV elimination. VHA's tremendous success in rapidly treating nearly all Veterans with HCV can provide a roadmap for other HCV elimination initiatives.